Viva Ventures Biotech Fund: Accessing $2 Trillion Global Pharmaceutical Market

VIVA VENTURE BIOTECH FUND

Viva Ventures Biotech Fund leverages 24 scientific GP partners to invest in 0->1 (idea to pre-clinical, first-in-class) drug discovery startups. The fund uses a peer-to-peer review method and selects 12-15 startups from 600+ deals reviewed per year. Viva Ventures targets blockbuster or billion dollar-sales new drug/ distributive innovative biotech startups with a success rate of over 60%, potential 3 X annual return, over 2-3 years investment period.

FUND PORTFOLIO

 

For more details about Viva Ventures Biotech Fund, please visit: www.VivaVenturesBiotech.com,

or send an inquiry to Xiliu@vivaventuresbiotech.com.

CHINA FUNDS

Huaxing Capital

CYZone Fund

Shunwei Capital

Huasheng Fund

Lightspeed China

Quantitative Strategy Fund

GLOBAL FUNDS

Dyal II​

Stepstone co-investment fund

Amino Capital

OTHER DIRECT INVESTMENT

Kickback

Funplus

Stripe

Wanda IPO

Alibaba IPO 

 

TEAM

 
 

CONTACT US

We look forward to new talents joining us or business collaboration. Please feel free to send your inquiry to services@jmcrpartners.com.

 

© 2019 by JMCR Partners. All right reserved. 

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon